NAUT FY 2024 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

NAUTNautilus Biotechnology, Inc.

$339M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$6M

Operating Income

-$81M

Net Income

-$71M

EPS (Diluted)

$-0.56

Cash Flow

Operating Cash Flow

-$59M

Free Cash Flow

-$61M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$243M

Total Liabilities

$34M

Stockholders' Equity

$209M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$6M	-$6M	-11.4%
Operating Income	-$81M	-$76M	-7.0%
Net Income	-$71M	-$64M	-11.2%